Overview
Seattle Cancer Care Alliance was formed in part to bring promising new treatments to patients faster. This means that people who have kidney cancer will find more treatment options at SCCA than might be found elsewhere, including participation in one of the clinical studies conducted at SCCA and its parent organizations, Fred Hutchinson Cancer Research Center and UW Medicine.
SCCA provides comprehensive, leading-edge treatment for people diagnosed with kidney cancer, including renal cell carcinoma, which accounts for 85 percent of kidney tumors. Kidney cancer is a difficult cancer to treat if it returns or spreads to other organs. It does not respond to traditional chemotherapy, but there is hope with immunotherapy. Currently, the best type of treatment for kidney cancer is participation in a clinical study.
Aggressive treatment and research can only take place at advanced medical facilities like Seattle Cancer Care Alliance, where specialized doctors treat patients with the most advanced treatments available.